JEPAX
Price
$13.43
Change
+$0.16 (+1.21%)
Updated
Apr 11 closing price
Net Assets
5.92B
PRRCX
Price
$10.51
Change
+$0.11 (+1.06%)
Updated
Apr 11 closing price
Net Assets
103.86M
Ad is loading...

JEPAX vs PRRCX

Header iconJEPAX vs PRRCX Comparison
Open Charts JEPAX vs PRRCXBanner chart's image
JPMorgan Equity Premium Income A
Price$13.43
Change+$0.16 (+1.21%)
VolumeN/A
Net Assets5.92B
Pioneer Equity Premium Income C
Price$10.51
Change+$0.11 (+1.06%)
VolumeN/A
Net Assets103.86M
JEPAX vs PRRCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JEPAX vs. PRRCX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEPAX is a Buy and PRRCX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
JEPAX has more cash in the bank: 5.92B vs. PRRCX (104M). PRRCX pays higher dividends than JEPAX: PRRCX (11.25) vs JEPAX (7.30). JEPAX was incepted earlier than PRRCX: JEPAX (7 years) vs PRRCX (15 years). PRRCX (2.16) is less costly to investors than JEPAX (0.85). JEPAX is a more actively managed with annual turnover of: 176.00 vs. PRRCX (114.00). JEPAX (1000) and PRRCX (1000) have matching initial minimum investment requirements. JEPAX annual gain was more profitable for investors over the last year : 0.92 vs. PRRCX (-7.14). JEPAX return over 5 years is better than : 63.02 vs. PRRCX (19.85).
JEPAXPRRCXJEPAX / PRRCX
Total Expense Ratio0.852.1639%
Annual Report Gross Expense Ratio0.852.1639%
Fund Existence7 years15 years-
Gain YTD-5.801-9.42762%
Front Load5%N/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets5.92B104M5,696%
Annual Yield % from dividends7.3011.2565%
Returns for 1 year0.92-7.14-13%
Returns for 3 years12.35-6.44-192%
Returns for 5 years63.0219.85317%
Returns for 10 yearsN/A-8.93-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGGHX35.960.37
+1.04%
American Funds Global Balanced R2E
ISCWX75.38N/A
N/A
Voya Multi-Manager International Sm Cp W
HGHIX35.92N/A
N/A
Hartford Healthcare I
CVTCX44.11N/A
N/A
Calamos Growth & Income C
ISCSX14.28N/A
N/A
VY® Columbia Contrarian Core S